Up To 50 SAR OFF Your First Order Use Code : APP50 | Get Free Delivery With No Minimum Order

Frequently bought together
ERECTA 100/MG FC TAB 4/FC TAB
- Sku : I-015422
Key features
ERECTA 100 mg film-coated tablets contain sildenafil 100 mg, a prescription medicine in tablet form. It works by selectively inhibiting PDE5, helping increase blood flow to the penis during sexual stimulation. It is used for the treatment of erectile dysfunction in adult men. This pack contains 4 film-coated tablets.- Brand: ERECTA
- Active Ingredient: SILDENAFIL 100mg
- Strength: 100mg
- Dosage Form: Film-coated tablet
- Pack Size: 4 Tablets
- Route: Oral use
- Prescription Status: Prescription
- Therapeutic Class: Sexual Health
- Pharmacological Group: PDE5 Inhibitors
- Drug Class: Phosphodiesterase type 5 (PDE5) inhibitor.
- Manufacturer: Jamjoom Pharmaceuticals Factory Company
- Country of Origin: Saudi Arabia
- SFDA Registration No.: 0309245853
- Shelf Life: 36 months
- Storage: store below 30°c
- Mechanism: PDE5 Inhibitor
- Onset Time: 30-60 minutes
Frequently bought together
Indications
Approved Uses
Erectile dysfunction in adult men
Off-Label Uses
Raynaud’s phenomenon/digital ischemia; prevention/treatment of high-altitude pulmonary edema (HAPE) in select situations. (Female sexual dysfunction is not an established, guideline-supported routine use.)
Dosage & Administration
Dosing by Condition
Erectile dysfunction: Initial 50 mg taken approximately 1 hour before sexual activity; may adjust to 25 mg or 100 mg based on response and tolerability; max 100 mg per dose, once daily. Pulmonary arterial hypertension: 20 mg three times daily (not this formulation/strength).
Initial Dose
50 mg approximately 1 hour before sexual activity (25 mg in elderly or those with hepatic/renal impairment)
Maintenance Dose
25-100 mg as needed, not more than once per day
Maximum Dose
100 mg per day for erectile dysfunction.
Children's Dosage
Not approved for children for erectile dysfunction.
Dose Adjustment Notes
Consider a lower starting dose (25 mg) in older adults (≥65 years), severe renal impairment (CrCl <30 mL/min), or hepatic impairment; use caution and lower starting dose with concomitant potent CYP3A4 inhibitors. With ritonavir: maximum 25 mg and do not repeat more often than every 48 hours.
How to Take
Swallow the film-coated tablet whole with water, taken as needed about 30-60 minutes (up to 4 hours) before sexual activity; sexual stimulation is required. Do not take more than 1 dose in 24 hours.
Side Effects
Common Side Effects
Headache, Flushing, Dyspepsia, Nasal congestion, Dizziness, Visual disturbances (color tinge, blurred vision), Back pain, Myalgia
Side Effect Frequency
Very common (≥10%): headache, flushing. Common (1-10%): dyspepsia, nasal congestion, dizziness, visual disturbances (e.g., color tinge/blurred vision), nausea. Also reported: back pain/myalgia (more prominent with PDE5 inhibitors, especially at higher doses). Rare/serious: priapism, severe hypotension (especially with contraindicated drugs), sudden vision loss (NAION), sudden hearing loss.
Safety & Warnings
Contraindications
Concomitant use with nitrates/nitrites or nitric oxide donors; concomitant use with guanylate cyclase stimulators (e.g., riociguat); hypersensitivity to sildenafil or excipients.
Warnings & Precautions
Assess cardiovascular status before prescribing; caution with alpha-blockers/other antihypertensives (symptomatic hypotension); caution in anatomical penile deformity or conditions predisposing to priapism (e.g., sickle cell disease, leukemia, myeloma); counsel to stop and seek care for sudden vision/hearing loss; avoid use in patients for whom sexual activity is inadvisable; caution with bleeding disorders/active peptic ulcer; not indicated for women for ED.
Age Restriction
Not indicated for erectile dysfunction in patients <18 years; pediatric use may exist only for specific sildenafil products/indications (e.g., PAH) and is not applicable to this ED product.
Driving Warning
May Cause Drowsiness
Drug Interactions
Drug Interactions
Major/contraindicated: nitrates/NO donors; riociguat. Clinically significant: alpha-blockers and other antihypertensives (additive hypotension); strong CYP3A4 inhibitors (e.g., ritonavir/cobicistat, ketoconazole/itraconazole, clarithromycin) increase exposure-use lower starting dose/avoid highest doses; CYP3A4 inducers (e.g., rifampin) decrease effect; cimetidine increases exposure.
Interaction Severity
MAJOR/Contraindicated: nitrates (including nitroglycerin/isosorbide) and riociguat due to profound hypotension. MAJOR (avoid/strict limits): potent CYP3A4 inhibitors-especially ritonavir/cobicistat (large exposure increase; dose limits). MODERATE: alpha-blockers and other antihypertensives (additive BP lowering), moderate CYP3A4 inhibitors (e.g., erythromycin/clarithromycin, ketoconazole) increase levels; excessive alcohol may worsen hypotension/dizziness. MINOR: strong CYP inducers (e.g., rifampin) may reduce effect.
Food Interaction
May be taken with or without food; a high-fat meal can delay onset (and reduce peak levels), so for faster onset take on an empty stomach.
Alcohol Interaction
Avoid
Special Populations
Pregnancy
Consult Doctor
Breastfeeding
Consult Doctor
Children
Not approved for children for erectile dysfunction.
Elderly
Start at 25 mg due to reduced clearance; titrate based on response and tolerability
Kidney Impairment
CrCl ≥30 mL/min: no adjustment; severe renal impairment (CrCl <30 mL/min) or ESRD: start 25 mg and titrate based on response/tolerability.
Liver Impairment
Mild-moderate hepatic impairment (Child-Pugh A/B): start 25 mg and titrate; severe hepatic impairment: avoid/not recommended (often treated as contraindicated in practice).
Storage & Patient Advice
Missed Dose
For erectile dysfunction, it is taken as needed (not scheduled), so there is no missed dose; do not take more than once in 24 hours.
Stopping the Medicine
Safe to stop anytime; no tapering required
Overdose
Symptoms: headache, flushing, dizziness, hypotension/syncope, visual disturbances, tachycardia, and priapism. Management: supportive care with vital-sign monitoring; consider activated charcoal if recent ingestion; hemodialysis is unlikely to help due to high protein binding; urgent evaluation for priapism or severe hypotension.
Patient Counseling
Take 30-60 minutes before sexual activity (up to 4 hours); sexual stimulation is required; do not exceed 1 dose/24 hours. Do not use with nitrates or riociguat; use caution with alpha-blockers/antihypertensives and limit alcohol. Seek urgent care for chest pain after dosing (do not take nitrates), sudden vision/hearing loss, or an erection lasting >4 hours.
Monitoring Requirements
No routine monitoring required for erectile dysfunction; monitor blood pressure when initiating therapy in patients on antihypertensives or alpha-blockers
Pharmacology
Mechanism of Action
Selective inhibition of cGMP-specific phosphodiesterase type 5 (PDE5) enhances nitric oxide-mediated increases in cGMP in the corpus cavernosum, causing smooth muscle relaxation and increased penile blood flow to facilitate erection with sexual stimulation.
Onset of Action
30-60 minutes.
Duration of Effect
4-6 hours.
Half-Life
3-5 hours.
Bioavailability
Approximately 41% (range about 25-63%).
Metabolism
Hepatic metabolism mainly via CYP3A4 (major) and CYP2C9 (minor) to an active metabolite (N-desmethyl sildenafil) with ~40% of parent potency.
Excretion
Primarily as metabolites in feces (~80%) and to a lesser extent in urine (~13%).
Protein Binding
Approximately 96%.
Product Information
Available Dosage Forms
For this SFDA product (ERECTA): film-coated tablet for oral use (100 mg). In general, sildenafil is also available in other markets as oral tablets, oral suspension/powder for suspension, and injection (IV) for pulmonary arterial hypertension.
Composition per Dose
Each film-coated tablet: Sildenafil 100 mg (as sildenafil citrate)
Generic Availability
Yes
OTC Alternatives
No OTC alternative
Mechanism
PDE5 Inhibitor
Onset Time
30-60 minutes
Legal Disclaimer - Al Mujtama Pharmacy
The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Al Mujtama Pharmacy assumes no legal or medical liability for:
- Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
- Any discrepancy between the information provided and the product's package insert or SFDA guidelines
- Any misuse of medication resulting from personal interpretation of the content displayed
Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.
By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.
Your health is a trust - always consult your doctor first.
-1744229570.gif)













